(Total Views: 130)
Posted On: 10/19/2023 4:27:49 PM
Post# of 93
NetworkNewsBreaks — SenesTech Inc. (NASDAQ: SNES) Featured in Virtual Webcast at Lytham Partners Fall 2023 Investor Conference
SenesTech (NASDAQ: SNES), the rodent fertility control experts and inventors of the only EPA-registered contraceptive for male and female rats, presented virtually in a webcast presentation as part of of the Lytham Partners Fall 2023 Investor Conference. The company’s president and CEO Joel Fruendt and CFO Tom Chesterman joined Lytham Partners Managing Partner Robert Blum to provide an overview of the company and its unique positioning in the market. “At SenesTech, we have a significant opportunity to create something special. It’s why I joined the company in November of last year. We are addressing one of the world’s most challenging problems – rodent control – through a completely different way than has ever been done before by addressing the root cause of the problem – reproduction,” Fruendt said during the presentation. “The existing solutions’ effectiveness, namely poisons, that are in the marketplace are limited by rats’ reproduction rates, resistance and aversion as well well as the enhanced social and political limitations on the use of poison… As communities increasingly look to deploy sustainable, effective solutions, fertility control fits right in with that objective. Products that can be paradigm-changing don’t come along very often but, when they do, they have an opportunity to change the way things have been done for generations, and at SenesTech, we can do that.”
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
SenesTech (NASDAQ: SNES), the rodent fertility control experts and inventors of the only EPA-registered contraceptive for male and female rats, presented virtually in a webcast presentation as part of of the Lytham Partners Fall 2023 Investor Conference. The company’s president and CEO Joel Fruendt and CFO Tom Chesterman joined Lytham Partners Managing Partner Robert Blum to provide an overview of the company and its unique positioning in the market. “At SenesTech, we have a significant opportunity to create something special. It’s why I joined the company in November of last year. We are addressing one of the world’s most challenging problems – rodent control – through a completely different way than has ever been done before by addressing the root cause of the problem – reproduction,” Fruendt said during the presentation. “The existing solutions’ effectiveness, namely poisons, that are in the marketplace are limited by rats’ reproduction rates, resistance and aversion as well well as the enhanced social and political limitations on the use of poison… As communities increasingly look to deploy sustainable, effective solutions, fertility control fits right in with that objective. Products that can be paradigm-changing don’t come along very often but, when they do, they have an opportunity to change the way things have been done for generations, and at SenesTech, we can do that.”
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)
